Search research articles
Contact Us
Filters
Showing results (51-60 of 93) with videos related to
Page
of 10
Sort By:
Vaccine
|
November 5, 1999
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults
P Richmond, D Goldblatt, P C Fusco, et al.
The Journal of Infectious Diseases
|
February 11, 2000
Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine
P Richmond, E Kaczmarski, R Borrow, et al.
Infection and Immunity
|
April 23, 2005
Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age
Y Al-Mazrou, M Khalil, R Borrow, et al.
Mucosal Immunology
|
July 19, 2012
Polysaccharide-protein conjugate vaccination induces antibody production but not sustained B-cell memory in the human nasopharyngeal mucosa
E T Clarke, N A Williams, P M Dull, et al.
Vaccine
|
April 20, 2001
Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls
R Borrow, J Southern, N Andrews, et al.
Clinical and Vaccine Immunology : CVI
|
January 21, 2011
Serum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults
H Findlow, R Borrow, P Hardelid, et al.
Clinical and Vaccine Immunology : CVI
|
January 1, 2010
Immunogenicity of a heptavalent conjugate pneumococcal vaccine administered concurrently with a combination diphtheria, tetanus, five-component acellular pertussis, inactivated polio, and Haemophilus influenzae type B vaccine and a meningococcal group C conjugate vaccine at 2, 3, and 4 months of age
S J Moss, A C Fenton, J Toomey, et al.
Vaccine
|
April 3, 2001
Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age
J C Bramley, T Hall, A Finn, et al.
FEMS Immunology and Medical Microbiology
|
May 9, 2000
Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA
M Guiver, R Borrow, J Marsh, et al.
Epidemiology and Infection
|
April 1, 1997
Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA
R Borrow, H Claus, M Guiver, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 93) with videos related to
Sort By:
Page
of 10
Vaccine
|
November 5, 1999
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults
P Richmond, D Goldblatt, P C Fusco, et al.
The Journal of Infectious Diseases
|
February 11, 2000
Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine
P Richmond, E Kaczmarski, R Borrow, et al.
Infection and Immunity
|
April 23, 2005
Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age
Y Al-Mazrou, M Khalil, R Borrow, et al.
Mucosal Immunology
|
July 19, 2012
Polysaccharide-protein conjugate vaccination induces antibody production but not sustained B-cell memory in the human nasopharyngeal mucosa
E T Clarke, N A Williams, P M Dull, et al.
Vaccine
|
April 20, 2001
Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls
R Borrow, J Southern, N Andrews, et al.
Clinical and Vaccine Immunology : CVI
|
January 21, 2011
Serum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults
H Findlow, R Borrow, P Hardelid, et al.
Clinical and Vaccine Immunology : CVI
|
January 1, 2010
Immunogenicity of a heptavalent conjugate pneumococcal vaccine administered concurrently with a combination diphtheria, tetanus, five-component acellular pertussis, inactivated polio, and Haemophilus influenzae type B vaccine and a meningococcal group C conjugate vaccine at 2, 3, and 4 months of age
S J Moss, A C Fenton, J Toomey, et al.
Vaccine
|
April 3, 2001
Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age
J C Bramley, T Hall, A Finn, et al.
FEMS Immunology and Medical Microbiology
|
May 9, 2000
Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA
M Guiver, R Borrow, J Marsh, et al.
Epidemiology and Infection
|
April 1, 1997
Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA
R Borrow, H Claus, M Guiver, et al.
Page
of 10